Inoncent Agueusop

588 total citations
15 papers, 311 citations indexed

About

Inoncent Agueusop is a scholar working on Dermatology, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Inoncent Agueusop has authored 15 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Dermatology, 5 papers in Immunology and Allergy and 3 papers in Molecular Biology. Recurrent topics in Inoncent Agueusop's work include Dermatology and Skin Diseases (7 papers), Allergic Rhinitis and Sensitization (4 papers) and Food Allergy and Anaphylaxis Research (3 papers). Inoncent Agueusop is often cited by papers focused on Dermatology and Skin Diseases (7 papers), Allergic Rhinitis and Sensitization (4 papers) and Food Allergy and Anaphylaxis Research (3 papers). Inoncent Agueusop collaborates with scholars based in Germany, United States and France. Inoncent Agueusop's co-authors include Oliver Distler, Alexandre Jagerschmidt, Eric Boitier, Stéphane Illiano, Dinesh Khanna, Christopher P. Denton, Yannick Allanore, Elena Goleva, Evgeny Berdyshev and Noah A. Levit and has published in prestigious journals such as Scientific Reports, Journal of Allergy and Clinical Immunology and Science Translational Medicine.

In The Last Decade

Inoncent Agueusop

13 papers receiving 307 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Inoncent Agueusop 110 108 72 70 65 15 311
Xiaoju Tang 130 1.2× 48 0.4× 44 0.6× 34 0.5× 15 0.2× 17 338
Caixia Li 90 0.8× 82 0.8× 207 2.9× 12 0.2× 62 1.0× 21 377
Corina Daniela Ene 97 0.9× 42 0.4× 68 0.9× 7 0.1× 28 0.4× 36 254
Akimasa Saito 66 0.6× 45 0.4× 102 1.4× 14 0.2× 13 0.2× 16 234
Vivian Laquer 34 0.3× 268 2.5× 98 1.4× 154 2.2× 26 0.4× 37 392
Nicole Busch 128 1.2× 102 0.9× 114 1.6× 8 0.1× 257 4.0× 6 459
Qiancheng Deng 70 0.6× 62 0.6× 106 1.5× 6 0.1× 50 0.8× 11 285
Yifan Hu 67 0.6× 71 0.7× 139 1.9× 13 0.2× 23 0.4× 23 268
Pierre‐Emmanuel Stoebner 126 1.1× 49 0.5× 48 0.7× 5 0.1× 31 0.5× 27 263
Samantha Beswick 76 0.7× 98 0.9× 68 0.9× 12 0.2× 152 2.3× 7 306

Countries citing papers authored by Inoncent Agueusop

Since Specialization
Citations

This map shows the geographic impact of Inoncent Agueusop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inoncent Agueusop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inoncent Agueusop more than expected).

Fields of papers citing papers by Inoncent Agueusop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inoncent Agueusop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inoncent Agueusop. The network helps show where Inoncent Agueusop may publish in the future.

Co-authorship network of co-authors of Inoncent Agueusop

This figure shows the co-authorship network connecting the top 25 collaborators of Inoncent Agueusop. A scholar is included among the top collaborators of Inoncent Agueusop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inoncent Agueusop. Inoncent Agueusop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Goleva, Elena, Evgeny Berdyshev, Simion Kreimer, et al.. (2025). Longitudinal integrated proteomic and metabolomic skin changes in patients with atopic dermatitis treated with dupilumab. Journal of Allergy and Clinical Immunology. 155(5). 1536–1546. 3 indexed citations
3.
Cork, Michael J., Evgeny Berdyshev, Elena Goleva, et al.. (2024). 52273 Dupilumab Provides Sustained Normalization of Skin Barrier Function in Children With Moderate-to-Severe Atopic Dermatitis. Journal of the American Academy of Dermatology. 91(3). AB34–AB34.
4.
Bronova, Irina, Evgeny Berdyshev, Elena Goleva, et al.. (2024). Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis. Journal of Allergy and Clinical Immunology. 153(2). AB5–AB5. 3 indexed citations
5.
Leung, Donald Y.M., Robert Bissonnette, Evgeny Berdyshev, et al.. (2023). Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin. Journal of Allergy and Clinical Immunology. 151(2). AB147–AB147. 2 indexed citations
6.
Leung, Donald Y.M., Robert Bissonnette, Simion Kreimer, et al.. (2023). Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin. The Journal of Allergy and Clinical Immunology In Practice. 11(5). 1421–1428. 12 indexed citations
7.
Margerie, Daniel, Christian Asbrand, Virginia Savova, et al.. (2023). Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis. Science Translational Medicine. 15(681). eabq4419–eabq4419. 44 indexed citations
8.
Berdyshev, Evgeny, Elena Goleva, Robert Bissonnette, et al.. (2022). Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis. Allergy. 77(11). 3388–3397. 77 indexed citations
9.
Berdyshev, Evgeny, Elena Goleva, Robert Bissonnette, et al.. (2022). Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis. Journal of Allergy and Clinical Immunology. 149(2). AB10–AB10. 5 indexed citations
10.
Vega, Rick B., Katie L. Whytock, Johann Gassenhuber, et al.. (2021). A Metabolomic Signature of Glucagon Action in Healthy Individuals With Overweight/Obesity. Journal of the Endocrine Society. 5(9). bvab118–bvab118. 16 indexed citations
11.
Agueusop, Inoncent, et al.. (2020). Short-term variability of the human serum metabolome depending on nutritional and metabolic health status. Scientific Reports. 10(1). 16310–16310. 24 indexed citations
12.
Allanore, Yannick, Oliver Distler, Alexandre Jagerschmidt, et al.. (2018). Double-blind, Randomized, 8-week Placebo-controlled followed by a 16-week open label extension study, with the LPA1 receptor antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis. Zurich Open Repository and Archive (University of Zurich). 70(10). 1634–1643. 34 indexed citations
13.
Agueusop, Inoncent, Stéphane Illiano, Corinne Rocher, et al.. (2017). OP0339 Identification of a transcriptomic signature correlated with modified rodnan skin score (MRSS) in patients with diffuse cutaneous systemic sclerosis. Annals of the Rheumatic Diseases. 76. 195–196. 1 indexed citations
14.
Allanore, Yannick, Oliver Distler, Alexandre Jagerschmidt, et al.. (2017). Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology. 70(10). 1634–1643. 80 indexed citations
15.
Doecke, Wolf‐Dietrich, Daniela Hornung, Inoncent Agueusop, et al.. (2016). Endometriosis Leads to an Increased Trefoil Factor 3 Concentration in the Peritoneal Cavity but Does Not Alter Systemic Levels. Reproductive Sciences. 24(2). 258–267. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026